Clinical Trial Update: Correlation Research Study: IQ2, NcIQ and IQ101 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for IQ2, NcIQ and IQ101 sponsored by Noninvasive Medical Technologies, Inc.; study lists Heart Failure, Dyspnea, and Hypertension …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea
• Heart Failure
• Hypertension

Drugs mentioned

• IQ101
• IQ2
• NcIQ

Snippet

Sponsor: Noninvasive Medical Technologies, Inc. | Conditions: Heart Failure, Dyspnea | Phase 1 | Status: COMPLETED